These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 24423116)

  • 1. Adoptive immunotherapy for cancer or viruses.
    Maus MV; Fraietta JA; Levine BL; Kalos M; Zhao Y; June CH
    Annu Rev Immunol; 2014; 32():189-225. PubMed ID: 24423116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
    Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
    Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Off-the-shelf' immunotherapy with iPSC-derived rejuvenated cytotoxic T lymphocytes.
    Ando M; Nakauchi H
    Exp Hematol; 2017 Mar; 47():2-12. PubMed ID: 27826124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology.
    Kalos M; June CH
    Immunity; 2013 Jul; 39(1):49-60. PubMed ID: 23890063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.
    Mercier-Letondal P; Marton C; Deschamps M; Ferrand C; Vauchy C; Chenut C; Baguet A; Adotévi O; Borg C; Galaine J; Godet Y
    Hum Gene Ther; 2018 Oct; 29(10):1202-1212. PubMed ID: 30136612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular immunology lessons from therapeutic T-cell receptor gene transfer.
    Thomas S; Stauss HJ; Morris EC
    Immunology; 2010 Feb; 129(2):170-7. PubMed ID: 20561357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cancer-specific mutations by T cell receptor gene therapy.
    Blankenstein T; Leisegang M; Uckert W; Schreiber H
    Curr Opin Immunol; 2015 Apr; 33():112-9. PubMed ID: 25728991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions.
    Curran KJ; Pegram HJ; Brentjens RJ
    J Gene Med; 2012 Jun; 14(6):405-15. PubMed ID: 22262649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered T cells for anti-cancer therapy.
    Turtle CJ; Hudecek M; Jensen MC; Riddell SR
    Curr Opin Immunol; 2012 Oct; 24(5):633-9. PubMed ID: 22818942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive immunotherapy for cancer.
    Ruella M; Kalos M
    Immunol Rev; 2014 Jan; 257(1):14-38. PubMed ID: 24329787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of endogenous T cells for adoptive transfer.
    Yee C
    Immunol Rev; 2014 Jan; 257(1):250-63. PubMed ID: 24329802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principles for adoptive T cell therapy of human viral diseases.
    Riddell SR; Greenberg PD
    Annu Rev Immunol; 1995; 13():545-86. PubMed ID: 7612234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered T cells: the promise and challenges of cancer immunotherapy.
    Fesnak AD; June CH; Levine BL
    Nat Rev Cancer; 2016 Aug; 16(9):566-81. PubMed ID: 27550819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically Engineered Natural Killer Cells as a Means for Adoptive Tumor Immunotherapy.
    Michen S; Temme A
    Crit Rev Immunol; 2016; 36(4):329-347. PubMed ID: 28322137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy.
    Rath JA; Arber C
    Cells; 2020 Jun; 9(6):. PubMed ID: 32570906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rebalancing immune specificity and function in cancer by T-cell receptor gene therapy.
    Udyavar A; Geiger TL
    Arch Immunol Ther Exp (Warsz); 2010 Oct; 58(5):335-46. PubMed ID: 20680493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in T-cell Immunotherapies.
    Stroncek DF; Reddy O; Highfill S; Panch SR
    Hematol Oncol Clin North Am; 2019 Oct; 33(5):825-837. PubMed ID: 31466607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive transfer of virus-specific and tumor-specific T cell immunity.
    Berger C; Turtle CJ; Jensen MC; Riddell SR
    Curr Opin Immunol; 2009 Apr; 21(2):224-32. PubMed ID: 19304470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition.
    Houot R; Schultz LM; Marabelle A; Kohrt H
    Cancer Immunol Res; 2015 Oct; 3(10):1115-22. PubMed ID: 26438444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moving receptor redirected adoptive cell therapy toward fine tuning of antitumor responses.
    Chicaybam L; Bonamino MH
    Int Rev Immunol; 2014 Oct; 33(5):402-16. PubMed ID: 24911925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.